Sage Journals: Discover world-class research

Abstract

Stable angina is a common but significant condition. Coronary artery disease is the most common cause of this disease. As well as symptom management, there is significant potential for secondary prevention of cardiovascular events in all patients with angina. This article gives a structured, evidence-based framework for managing stable angina and the risk factors for coronary artery disease in the primary care setting.

Get full access to this article

View all access options for this article.

References

Awtry

E. H.

Loscalzo

(2000) Aspirin. Circulation 101: 1206–1218. doi: 10.1161/01.CIR.101.10.1206.

Baker

W. L.

Coleman

C. I.

Kluger

Reinhart

K. M.

Talati

Quercia

White

C. M.

(2009) Systematic review: Comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease. Annals of Internal Medicine 151(12): 861–871. doi: 10.7326/0003-4819-151-12-200912150-00162.

Critchley, J. & Capewell, S. (2004). Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Systematic Reviews 1, CD003041. doi: 10.1002/14651858.CD003041.pub2.

DVLA. (2013). Angina and driving. Retrieved from www.gov.uk/angina-and-driving.

Huang

H. L.

Fox

K. A.

(2012) The impact of beta-blockers on mortality in stable angina: A meta-analysis. Scottish Medical Journal 57: 69–75. doi: 10.1258/smj.2011.011274.

Law

M. R.

Morris

J. K.

Wald

N. J.

(2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. British Medical Journal 19(338): 1665doi: 10.1136/bmj.b1665.

Medicines and Healthcare Products Regulatory Authority. (2010). Clopidogrel and proton pump inhibitors: Interaction—updated advice. Retrieved from www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087711.

Montalescot

Sechtem

Achenbach

Andreotti

Arden

Budaj

Zamorano

J. L.

(2013) ESC guidelines on the management of stable coronary artery disease: The Task Force on the Management of Stable Coronary Artery Disease of the European Society of Cardiology. European Heart Journal 34(38): 2949–3003. doi: 10.1093/eurheartj/eht296.

Myers

(2003) Exercise and cardiovascular health. Circulation 107: e2–e5. doi: 0.1161/01.CIR.0000048890.59383.8D.

10.

NICE. (2006a). Brief interventions and referral for smoking cessation in primary care and other settings: Quick reference guide. Retrieved from www.nice.org.uk/nicemedia/live/11375/31864/31864.pdf.

11.

NICE. (2006b). Obesity. Retrieved from http://guidance.nice.org.uk/CG43/Guidance/Section.

12.

NICE. (2007). MI: Secondary prevention in primary and secondary care for patients following a myocardial infarction. Retrieved from www.nice.org.uk/nicemedia/pdf/CG48NICEGuidance.pdf.

13.

NICE. (2008). Type 2 diabetes. Retrieved from www.nice.org.uk/nicemedia/pdf/cg66niceguideline.pdf.

14.

NICE. (2010a). Chest pain of recent onset. Retrieved from www.nice.org.uk/nicemedia/live/12947/47938/47938.pdf.

15.

NICE. (2010b). Prevention of cardiovascular disease. Retrieved from www.nice.org.uk/nicemedia/live/13024/49273/49273.pdf.

16.

NICE. (2010c). Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. Retrieved from www.nice.org.uk/nicemedia/pdf/cg67niceguideline.pdf.

17.

NICE. (2011a). Clinical knowledge summary: Chest pain. Retrieved from http://cks.nice.org.uk/chest-pain#!topicsummary.

18.

NICE. (2011b). Management of stable angina. Retrieved from www.nice.org.uk/nicemedia/live/13549/55660/55660.pdf.

19.

NICE. (2011c). Hypertension: Clinical management of primary hypertension in adults. Retrieved from www.nice.org.uk/nicemedia/live/13561/56008/56008.pdf.

20.

NICE. (2012). Clinical knowledge summary: Hypertension: Managing abnormal tests. Retrieved from http://cks.nice.org.uk/hypertension-not-diabetic#!prescribinginfosub:6.

21.

Perk

de Backer

Gohlke

Graham

Reiner

Verschuren

Zannad

(2012) European guidelines on cardiovascular disease prevention in clinical practice. The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. European Heart Journal 33(13): 1635–1701. doi: 10.1093/eurheartj/ehs092.

22.

Piepoli

M. F.

Corra

Benzer

Bjarnason-Wehrens

Dendale

Gaita

Schmid

J. P.

(2010) Secondary prevention through cardiac rehabilitation: From knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. European Journal of Cardiovascular Prevention and Rehabilitation 17: 1–17. doi: 10.1097/HJR.0b013e3283313592.

23.

RCGP. (2012). Clinical example 3.12: Cardiovascular health. Retrieved from www.rcgp.org.uk/gp-training-and-exams/∼/media/Files/GP-training-and-exams/Curriculum-2012/RCGP-Curriculum-3-12-Cardiovascular-Health.ashx.